Skip to content

Sanara MedTech Inc. SMTI Income Statement

FY'25FY'24FY'23FY'22
$103.14M+19.0%$86.67M+33.4%$64.99M+41.8%$45.84M+50.7%
$7.52M-7.6%$8.14M+3.7%$7.85M+23.5%$6.36M+175%
$95.62M+21.8%$78.53M+37.4%$57.14M+44.7%$39.48M+40.5%
92.7%+2.1pp90.6%+2.7pp87.9%+1.8pp86.1%-6.3pp
$5.27M+46.5%$3.6M-12.9%$4.13M+22.7%$3.37M+503%
$80.64M+10.8%$72.79M+27.7%$56.99M+24.0%$45.98M+63.9%
$3.09M-14.2%$3.6M-2.0%$3.68M+55.0%$2.37M+297%
$90.84M+13.7%$79.91M+30.2%$61.35M+18.0%$52M+78.0%
$4.79M+447%-$1.38M+67.3%-$4.22M+66.3%-$12.52M-69.7%
4.6%+6.2pp-1.6%+4.9pp-6.5%+20.8pp-27.3%-3.1pp
$6.76M+116%$3.13M+558%$475.78K+67.1%$284.75K+39,949%
$21.98K
-$7.7M-141%-$3.2M-1,322%-$224.75K+85.9%-$1.59M-158%
-$952.47K
-$37.56M-289%-$9.66M-125%-$4.3M+45.8%-$7.94M-0.2%
-36.4%-25.3pp-11.2%-4.5pp-6.6%+10.7pp-17.3%+8.7pp
-$393,124.05
-$4.31
-$4.36-282%-$1.14-119%-$0.52+48.0%-$1.00+7.4%
-$4.34-281%-$1.14-119%-$0.52+48.0%-$1.00+7.4%
34.7M+2.5%33.9M+2.7%33M
34.5M+1.7%33.9M+2.7%33M+5.1%31.4M+7.7%
$1.84M
-$4.31
$21.98K
-$7.7M-141%-$3.2M-1,322%-$224.75K+85.9%-$1.59M-158%
$509.23K-18.5%$624.45K+192%$214.06K-23.5%$280K+443%
$103.14M+19.0%$86.67M+33.4%$64.99M+41.8%$45.84M+89.9%
$4.79M+447%-$1.38M+67.3%-$4.22M+66.3%-$12.52M-69.7%
$8.73M+146%$3.55M+756%-$540.13K+94.7%-$10.15M-49.7%
$8.73M+146%$3.55M+756%-$540.13K+94.7%-$10.15M-49.7%
8.5%+4.4pp4.1%+4.9pp-0.8%+21.3pp-22.1%+0.2pp
$4.79M+447%-$1.38M+67.3%-$4.22M+66.3%-$12.52M-69.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Sanara MedTech Inc.'s revenue?
Sanara MedTech Inc. (SMTI) generated $107.5M in revenue over the trailing twelve months, up 17.4% year over year.
Is Sanara MedTech Inc. profitable?
Sanara MedTech Inc. is not currently profitable: it reported a net loss of $33.6M over the trailing twelve months, a -31.2% net margin.
What are Sanara MedTech Inc.'s profit margins?
Gross margin is 92.9% and operating margin is 6.1%, with a -31.2% net margin.
What is Sanara MedTech Inc.'s earnings per share?
Sanara MedTech Inc.'s diluted EPS over the trailing twelve months is $-3.90.
Where does Sanara MedTech Inc.'s income statement data come from?
Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.